We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Multiplex Assay Detects Pathogens in NF Patients

By LabMedica International staff writers
Posted on 23 Apr 2019
Necrotizing fasciitis (NF) is a life-threatening deep soft tissue infection characterized by rapidly progressive necrosis of the fascia and the adjacent soft tissues. NF of the extremities is associated with high mortality rates, and immediate surgical intervention is required upon detection of NF infections.

Early diagnosis and bacterial identification are essential for adequate surgical treatment and appropriate antibiotic administration in patients with NF. The clinical signs and symptoms of NF caused by Gram-positive and Gram-negative microorganisms are characteristically indistinguishable at the time of presentation. Moreover, it takes 3 to 4 days to obtain the results of microbiological analysis and antimicrobial sensitivity testing of the specimens.

Image: An area of mild erythema around varicella lesion on the thigh of a young boy progressed to necrotizing fasciitis caused by group A Streptococcus (Photo courtesy of Dr. E. P. Dellinger, MD).
Image: An area of mild erythema around varicella lesion on the thigh of a young boy progressed to necrotizing fasciitis caused by group A Streptococcus (Photo courtesy of Dr. E. P. Dellinger, MD).

Scientists from Chang Gung Memorial Hospital (Taoyuan City, Taiwan) collected samples from 99 patients with surgically confirmed NF of the extremities who were hospitalized consecutively between June 2015 and November 2017. Two sets of blood and tissue samples were collected from all patients; one set was sent to a microbiology laboratory for bacterial identification and the other set was sent to an immunohistochemistry laboratory for polymerase chain reaction (PCR) amplification.

The culture specimens were obtained from the infected wounds or the blood, and were identified by microbiological evaluation. Genomic bacterial DNA extraction was performed and 16S rDNA universal PCR was performed for each sample to validate the results of the multiplex PCR assay. Total genomic DNA was purified using a Geneaid Bacteria Genomic DNA Kit and amplified. PCR amplicons were analyzed by electrophoresis in 2% agarose gel.

The multiplex PCR results for the blood samples showed negative findings. The multiplex PCR results for the tissue specimens showed 28 positive findings. Fourteen (87.5%) of the 16 Vibrio vulnificus culture-positive tissue specimens, six (75%) of the eight Aeromonas hydrophila culture-positive tissue specimens, and four (100%) of the four methicillin-resistant Staphylococcus aureus (MRSA) culture-positive tissue specimens were positive by PCR. Similarly, two (100%) of the group A Streptococcus and two (100%) of the group B Streptococcus were PCR-positive.

The authors concluded that the accuracy rate of the multiplex PCR presenting positive results in these culture-positive tissue samples was 87.5% (28/32). This suggests that multiplex PCR of tissue specimens may be a useful and rapid diagnostic tool for the detection of these lethal microorganisms in patients with NF. The study was published in the April 2019 issue of the International Journal of Infectious Diseases.

Related Links:
Chang Gung Memorial Hospital


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Vitamin B12 Test
CHORUS CLIA VIT B12
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Latest Microbiology News

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment